Lodi, WI, United States of America

Larry F Whitesell

This inventor holds 1 USPTO granted patent. Top assignee: Mirus Bio Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry F Whitesell. Retrieved from https://idiyas.com/inventor/larry-f-whitesell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Larry F Whitesell: Innovator in Cardiac Gene Therapy

Introduction

Larry F Whitesell is a notable inventor based in Lodi, Wisconsin, who has made significant contributions to the field of gene therapy. His innovative work focuses on the delivery of nucleic acids to cardiac tissue, which has important implications for medical research and treatment.

Latest Patents

Larry F Whitesell holds a patent for a process titled "Process for delivering nucleic acids to cardiac tissue." This patent describes a method for introducing a composition consisting of a nucleic acid into a blood vessel, which subsequently delivers the nucleic acid to cardiac tissue cells in mammals. The nucleic acid can be DNA, RNA, plasmid DNA, or viral, and this process is aimed at advancing gene therapy and research.

Career Highlights

Larry is associated with Mirus Bio Corporation, a company that specializes in innovative solutions for gene delivery. His work at Mirus Bio Corporation has positioned him as a key figure in the development of advanced therapeutic techniques.

Collaborations

Throughout his career, Larry has collaborated with notable professionals in the field, including Jon Asher Wolff and Hans Herweijer. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Larry F Whitesell's contributions to cardiac gene therapy through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…